Literature DB >> 34129817

Innate immune cells in the tumor microenvironment.

Ming O Li, Natalie Wolf, David H Raulet, Leila Akkari, Mikael J Pittet, Paulo C Rodriguez, Rosandra N Kaplan, Ariel Munitz, Zemin Zhang, Sijin Cheng, Nina Bhardwaj.   

Abstract

The tumor immune microenvironment (TIME) is a complex ecosystem that contains adaptive and innate immune cells that have tumor-promoting and anti-tumor effects. There is still much to learn about the diversity, plasticity, and functions of innate immune cells in the TIME and their roles in determining the response to immunotherapies. Experts discuss recent advances in our understanding of their biology in cancer as well as outstanding questions and potential therapeutic avenues.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34129817     DOI: 10.1016/j.ccell.2021.05.016

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   38.585


  11 in total

1.  m6A nuclear condensates support AML.

Authors:  Eytan Zlotorynski
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07       Impact factor: 94.444

Review 2.  The Single-Cell Level Perspective of the Tumor Microenvironment and Its Remodeling by CAR-T Cells.

Authors:  Sanxing Gao; Ryohichi Sugimura
Journal:  Cancer Treat Res       Date:  2022

Review 3.  Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy.

Authors:  Sharon Grisaru-Tal; Marc E Rothenberg; Ariel Munitz
Journal:  Nat Immunol       Date:  2022-08-24       Impact factor: 31.250

4.  Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas.

Authors:  Jingwei Zhang; Zeyu Wang; Hao Zhang; Ziyu Dai; Xisong Liang; Shuwang Li; Xun Zhang; Fangkun Liu; Zhixiong Liu; Kui Yang; Quan Cheng
Journal:  Front Cell Dev Biol       Date:  2022-02-09

Review 5.  Neutrophils: New Critical Regulators of Glioma.

Authors:  Guanyu Wang; Jinpeng Wang; Chaoshi Niu; Yan Zhao; Pengfei Wu
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 6.  Osthole: An up-to-date review of its anticancer potential and mechanisms of action.

Authors:  Shaojie Yang; Wanlin Dai; Jingnan Wang; Xiaolin Zhang; Yuting Zheng; Shiyuan Bi; Liwei Pang; Tengqi Ren; Ye Yang; Yang Sun; Zhuyuan Zheng; Shuodong Wu; Jing Kong
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

Review 7.  Immunotherapy of targeting MDSCs in tumor microenvironment.

Authors:  Hongshu Sui; Shengyi Dongye; Xiaocui Liu; Xinghua Xu; Li Wang; Christopher Q Jin; Minhua Yao; Zhaoqing Gong; Daniel Jiang; Kexin Zhang; Yaling Liu; Hui Liu; Guomin Jiang; Yanping Su
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

8.  Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.

Authors:  Dongni Zhang; Wenping Lu; Zhili Zhuo; Heting Mei; Xiaoqing Wu; Yongjia Cui
Journal:  Discov Oncol       Date:  2022-08-21

Review 9.  Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment.

Authors:  Xiaoxia Huang; Yao Wang; Wenhui Yang; Jing Dong; Lin Li
Journal:  Front Nutr       Date:  2022-08-25

10.  Characteristic of Molecular Subtypes in Lung Squamous Cell Carcinoma Based on Autophagy-Related Genes and Tumor Microenvironment Infiltration.

Authors:  Jinjie Wang; Jiaqi Zhu; Yijie Tang; Anping Zhang; Tingting Zhou; Youlang Zhou; Jiahai Shi
Journal:  J Oncol       Date:  2022-09-13       Impact factor: 4.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.